CREM062i-BT2
| Cell Line Alias | BT2 |
| Cell Type | Human iPS |
| Disease | Beta Thalassemia |
| Diagnosis Information | Diagnosis of Beta Thalassemia was physician reported |
| Genetic Alteration/Mutation | HBB |
| Genetic Alteration/Mutation Information | Compound heterozygous: IVS I-6 T>C ??+-thalassemia mutation;Codon 39 CAG>TAG or Glun39Term ??0-thalassemia mutation. |
| Sex | Male |
| Age at Collection | 6 Years |
| Ethnicity | African American |
| Ethnicity Information | Physician reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Viral transfection (Lentivirus: Oct4, Klf4, Sox2, cMyc) |
| Tissue Origin | Blood |
| Provider | Boston University and Boston Medical Center's Center for Regenerative Medicine (CReM) - Dr. Steinberg, Dr. Mostoslavsky, Dr. Murphy |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Sickle Cell Anemia (Dr. Steinberg, Dr. Mostoslavsky, Dr. Murphy, Boston University and Boston Medical Center's Center for Regenerative Medicine) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB66781 | mTeSR1/Matrigel | 16 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
